| Page 28 | Cafepharma

You are here

Primary tabs

Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer

Post date: December 20, 2018 - 10:19am

Relay Therapeutics Banks $400 Million in Series C Round

Post date: December 20, 2018 - 9:57am

Equillium's EQ001 Granted FDA Fast Track Designation for Acute Graft-Versus-Host Disease

Post date: December 19, 2018 - 10:15am

Auron and Elucidata Launch AI Driven Collaboration to Identify Targets for Differentiation-Based Oncology Therapies

Post date: December 19, 2018 - 10:00am

Annexon Biosciences Closes $75 Million Series C Round

Post date: December 19, 2018 - 9:39am

Money Keeps Flowing Into Life Science Funds – RiverVest Closes Oversubscribed 184.4 Million Fund

Post date: December 18, 2018 - 9:30am

Versant Raises $100 Million to Develop Venture Ecosystem in Canadian Life Sciences Arena

Post date: December 17, 2018 - 11:02am

Merck to Acquire Animal Tracking and Monitoring Company

Post date: December 14, 2018 - 10:40am

Two Life Science Accelerators Announce New Lab Space

Post date: December 14, 2018 - 10:03am

Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine

Post date: December 14, 2018 - 9:10am

Pages